News, Media & Events
OxSonics CEO, Jérôme Marzinski, gives interview to The Medicine Maker.
Jérôme Marzinski appointed as Chief Executive Officer
Preclinical data demonstrates SonoTran® increased efficacy of ADCT-601 in human renal cancer model
OxSonics presents preclinical data demonstrating SonoTran® enhanced the delivery and efficacy of an oncolytic virus in a murine bladder cancel model
OxSonics to present efficacy data from its collaboration with ADC Therapeutics at the EORTC-NCI-AACR Symposium
2022 IEEE Int Ultrasonics Symposium
Senior Ultrasound Engineers, Dr Paul Boulos and Dr Anant Shah, will be in attendance for discussions with suppliers and technology providers.
14th Int. Oncolytic Virotherapy Conference (IOVC) 2022
Karuizawa, Nagano, Japan
Research Scientist, Dr Erika Vojtasova, will be presenting a poster entitled, “Ultrasound-enhanced delivery and improved efficacy of an oncolytic Vaccinia virus in a murine bladder cancer model.”
34th EORTC-NCI-AACR Symposium
Senior Development Scientist, Dr Massimo Masiero, will be delivering a poster entitled, “Ultrasound-induced cavitation enhances therapeutic efficacy of AXL-targeting ADC leading to improved survival in a human xenograft model of renal cancer.”
CBO, Nick Adams, available for partnering discussions.
8th Int. Symposium on Focused Ultrasound (FUS Foundation)
Bethesda, Maryland, USA
CTO, Dr Christian Coviello, will be attending to meeting with research partners, suppliers, and investors.
183rd Meeting of ASA
Nashville, TN, USA
CTO, Dr Christian Coviello, is giving an invited talk on SonoTran Particles and cavitation metrology of manufacturing bubbles.